Substance Use Prevention for Recently Displaced Adults - SUPRA (R33) RCT (SUPRA RCT R33)
研究概览
详细说明
The war in Ukraine has provoked the world's current largest humanitarian displacement: since February 2022, over 13 million people, i.e., one-third of Ukrainians, have been forced to leave their homes, resulting in nearly 6 million internally displaced persons (IDPs). War and humanitarian emergencies may exacerbate substance use, but the incidence and prevalence of unhealthy substance use in humanitarian settings, including Ukraine, are currently largely unknown. This lack of data limits the ability to tailor targeted, effective preventive substance use interventions for these mobile populations. Addressing this knowledge gap is an immense priority for Ukraine, where rates of substance use were high even prior to the Russian invasion in February 2022, and in other settings hosting large populations of IDPs, including the United States.
To determine the feasibility, acceptability, and preliminary effectiveness of the intervention among IDPs, a RCT to evaluate implementation and substance use outcomes associated with the intervention at 1 and 6 months.
The investigators hypothesize that an ACT-based intervention delivered in a humanitarian context will help displaced persons in Ukraine build skills to manage stress and prevent or reduce substance use behaviors, ultimately mitigating the onset of substance use disorders.
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名:Karsten Lunze, MD DrPH MPH
- 电话号码:617-414-6933
- 邮箱:lunze@bu.edu
研究联系人备份
- 姓名:Kimberly Hook, PhD MA
- 邮箱:kmhook@hsph.harvard.edu
学习地点
-
-
-
Kyiv、乌克兰
- Alliance for Public Health
-
接触:
- Pavlo Smyrnov
- 电话号码:+380 44 490-5485
- 邮箱:Smyrnov@aph.org.ua
-
-
参与标准
资格标准
适合学习的年龄
- 成人
- 年长者
接受健康志愿者
描述
Inclusion Criteria:
- Age 18 or over
- Have been displaced at least once due to Anti-Terrorist Operation (ATO) or full-scale invasion since 2014
- Self-reported use of at least one substance other than alcohol and tobacco within the past 3 months
- Ability to provide informed consent and speak Ukrainian or Russian
Exclusion Criteria:
- Self-reported diagnosis of a substance use disorder
- Inability to provide informed consent
学习计划
研究是如何设计的?
设计细节
- 主要用途:预防
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:ACT Therapy
Participants randomized to this group will receive the ACT intervention
|
The ACT group intervention will involve a mixture of didactic instruction, discussion, and experiential activities.
ACT will help internally displaced persons to manage stress and prevent or reduce substance use behaviors, ultimately mitigating the onset of substance use disorders.
|
|
有源比较器:Attention Control
Participants in the control group will receive minimally enhanced usual care to receive treatment as usual enhanced by a health information group session.
|
Usual care will be minimally enhanced by providing participants with an educational information session that provides information on health promotion.
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Feasibility of the ACT Intervention
大体时间:1 month and 6 months
|
Feasibility will be assessed using the 14-item feasibility subscales of the Applied Mental Health Research Group Implementation Measure (AMHR-IM).
Each item is rated on a 4-point scale where "0" means "not at all" and "3" means "a lot".
The overall Feasibility score is calculated as the mean (average) across all 14 completed items, where higher scores (closer to 3) reflect a higher level of perceived feasibility of the intervention.
|
1 month and 6 months
|
|
Acceptability of the ACT Intervention
大体时间:1 month and 6 months
|
Acceptability will be assessed using the 17-item acceptability subscales of the Applied Mental Health Research Group Implementation Measure (AMHR-IM).
Each item is rated on a 4-point Likert scale where "0" means "not at all" and "3" means "a lot".
The overall Acceptability score is calculated as the mean (average) across all 17 completed items, where higher scores (closer to 3) reflect a higher level of perceived acceptability of the intervention.
|
1 month and 6 months
|
合作者和调查者
调查人员
- 首席研究员:Karsten Lunze, MD DrPH MPH、Boston University Chobanian & Avedisian School of Medicine
研究记录日期
研究主要日期
学习开始 (估计的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.